Demo-day access
Get first look at AI safety founders presenting live, before they open to the wider investor market. Earlier look, better terms.
Investors
Get demo-day access and warm introductions to vetted AI safety startups before they reach the broader market. Invest alongside the field's leading experts and back the companies solving the top 10 existential threats of AI.
What you get
Every founder in the Accelerator is vetted against the top 10 AI safety threat landscape by experts who built the standards themselves.
Get first look at AI safety founders presenting live, before they open to the wider investor market. Earlier look, better terms.
Direct intros to the founders our experts back, not cold inbound. We only make introductions we'd stake our own reputation on.
Our network includes AI safety researchers from Yale, IEEE, Bristol Robotics Lab, UT Austin, and Sorbonne. Ask the hard technical questions with people who can answer them.
AI safety infrastructure, tooling, and governance startups are 3 to 5 years behind the AI capability wave. The window to take early positions is open now.
The EU AI Act binds on 2 August 2026. Every high-risk AI system needs compliance infrastructure. Regulation is a forcing function for the companies you'll meet here.
Attend the AI Safety Summit and the policy track. Understand the regulatory and geopolitical forces shaping what will become the most scrutinised industry on earth.
The expert network
Better Societies works with the researchers who wrote the IEEE ethics frameworks, the academics who advise global governments on AI risk, and the founders who have shipped AI safety products. These are the people vetting the deal flow you access.
Roman Yampolskiy
Univ. of Louisville
Wendell Wallach
Yale Center for Bioethics
Alan Winfield
Bristol Robotics Lab / IEEE
Raja Chatila
Sorbonne / IEEE
Risto Miikkulainen
UT Austin / Cognizant
Toby Walsh
UNSW Sydney
Next step
Email us and tell us a little about your fund or investment focus. We'll set up a call to walk you through the current cohort and upcoming demo day.